Optimal Asset Management’s Quest Diagnostics DGX Stock Holding History

Optimal Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$6.31M	Buy	43,418 +53	+0.1%	+$7.75K	0.79%	21
2021 Q2	$5.72M	Hold	43,365	–	–	0.68%	28
2021 Q1	$5.57M	Buy	43,365 +4,500	+12%	+$555K	0.72%	26
2020 Q4	$4.63M	Hold	38,865	–	–	0.66%	28
2020 Q3	$4.45M	Sell	38,865 -456	-1%	-$53.9K	0.64%	31
2020 Q2	$4.48M	Sell	39,321 -41,970	-52%	-$4.45M	0.73%	19
2020 Q1	$6.53K	Buy	81,291 +37,933	+87%	+$3.93M	0.61%	29
2019 Q4	$4.63M	Buy	+43,358	New	+$4.52M	0.7%	22

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Optimal Asset Management's DGX Position: Q3 2021 in Review

Optimal Asset Management increased its Quest Diagnostics (DGX) stake by 0.12% in Q3 2021, buying an estimated $7.75K and bringing the position to 43,418 shares worth $6.31M. The position accounts for 0.79% of the portfolio, ranked #21.

Optimal Asset Management first reported a position in DGX in Q4 2019 and has held it in 8 quarters since. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

Optimal Asset Management held 43,418 shares of Quest Diagnostics worth $6.31M as of Q3 2021.
Optimal Asset Management bought 53 Quest Diagnostics shares in Q3 2021, an estimated $7.75K.
Quest Diagnostics made up 0.79% of Optimal Asset Management's portfolio in Q3 2021, its #21 holding.
Optimal Asset Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 8 quarters since.
837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.